Company profile for Evox Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics. Backed by leading venture capital groups and leveraging a comprehensive dominant intellectual property portfolio Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment o...
Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics. Backed by leading venture capital groups and leveraging a comprehensive dominant intellectual property portfolio Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of rare and severe diseases with limited treatment options for patients and their families.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Evox Therapeutics Limited Oxford Science Park Medawar Centre 2nd Floor East Bu...
Telephone
Telephone
+44 (0)1865 819140
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251111411198/en/Evox-Therapeutics-Appoints-Douglas-Treco-Ph.D.-to-Board-of-Directors

BUSINESSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/07/16/3116135/0/en/Evox-Therapeutics-Expands-Scientific-Advisory-Board.html

GLOBENEWSWIRE
16 Jul 2025

https://www.globenewswire.com/news-release/2024/04/29/2870920/0/en/Evox-Therapeutics-Names-Co-Founder-Dr-Per-Lundin-as-Chief-Executive-Officer.html

GLOBENEWSWIRE
29 Apr 2024
Evox Therapeutics Taps Dr. Per Lundin as CEO
Evox Therapeutics Taps Dr. Per Lundin as CEO

29 Apr 2024

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2024-04-29/evox-therapeutics-taps-dr-per-lundin-as-ceo/?widget=listSection

CONTRACT PHARMA
29 Apr 2024

https://www.globenewswire.com/news-release/2023/08/09/2721310/0/en/Landmark-paper-in-Nature-Communications-highlights-continued-advances-in-Evox-Therapeutics-s-proprietary-exosome-engineering-platform.html

GLOBENEWSWIRE
09 Aug 2023

https://www.globenewswire.com/news-release/2023/08/04/2718741/0/en/Evox-Therapeutics-enters-into-agreement-to-advance-next-generation-exosome-delivered-AAV-gene-therapy-for-the-treatment-of-heart-disease.html

GLOBENEWSWIRE
04 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty